BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 35688535)

  • 1. Pearls and Pitfalls in Lung Cancer CT Screening.
    Godoy MCB; Lago EAD; Pria HRFD; Shroff GS; Strange CD; Truong MT
    Semin Ultrasound CT MR; 2022 Jun; 43(3):246-256. PubMed ID: 35688535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
    JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose computed tomography lung cancer screening: Clinical evidence and implementation research.
    Lancaster HL; Heuvelmans MA; Oudkerk M
    J Intern Med; 2022 Jul; 292(1):68-80. PubMed ID: 35253286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Cancer Screening.
    Choi HK; Mazzone PJ
    Med Clin North Am; 2022 Nov; 106(6):1041-1053. PubMed ID: 36280331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
    Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
    Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.
    Pinsky PF; Gierada DS; Black W; Munden R; Nath H; Aberle D; Kazerooni E
    Ann Intern Med; 2015 Apr; 162(7):485-91. PubMed ID: 25664444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing lung cancer screening: the US experience.
    Aberle DR
    Clin Radiol; 2017 May; 72(5):401-406. PubMed ID: 28069160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung Cancer Screening: Computed Tomography Radiation and Protocols.
    Murugan VA; Kalra MK; Rehani M; Digumarthy SR
    J Thorac Imaging; 2015 Sep; 30(5):283-9. PubMed ID: 25856411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New evidence supporting lung cancer screening with low dose CT & surgical implications.
    Dezube AR; Jaklitsch MT
    Eur J Surg Oncol; 2020 Jun; 46(6):982-990. PubMed ID: 32113886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit-to-radiation-risk of low-dose computed tomography lung cancer screening.
    Hendrick RE; Smith RA
    Cancer; 2024 Jan; 130(2):216-223. PubMed ID: 37909872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
    Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
    Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current estimate of costs of lung cancer screening in the United States.
    Mauchley DC; Mitchell JD
    Thorac Surg Clin; 2015 May; 25(2):205-15. PubMed ID: 25901564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evidence for low-dose CT screening of lung cancer.
    Ruchalski K; Gutierrez A; Genshaft S; Abtin F; Suh R
    Clin Imaging; 2016; 40(2):288-95. PubMed ID: 26362352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Lung Cancer With Low-Dose Computed Tomography: Grand Rounds Discussion From the Beth Israel Deaconess Medical Center.
    Smetana GW; Boiselle PM; Schwartzstein RM
    Ann Intern Med; 2015 Apr; 162(8):577-82. PubMed ID: 25894026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necessity of organized low-dose computed tomography screening for lung cancer: From epidemiologic comparisons between China and the Western nations.
    Gou HF; Liu Y; Yang TX; Zhou C; Chen XZ
    Oncotarget; 2017 Jan; 8(1):1788-1795. PubMed ID: 27705946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Lung Cancer Screening Results Based on Individual Prediction of Current and Future Lung Cancer Risks.
    Robbins HA; Cheung LC; Chaturvedi AK; Baldwin DR; Berg CD; Katki HA
    J Thorac Oncol; 2022 Feb; 17(2):252-263. PubMed ID: 34648946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer screening: a critical appraisal.
    Kian W; Zemel M; Levitas D; Alguayn W; Remilah AA; Rahman NA; Peled N
    Curr Opin Oncol; 2022 Jan; 34(1):36-43. PubMed ID: 34652284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
    Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
    Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials.
    Silva M; Pastorino U; Sverzellati N
    Clin Radiol; 2017 May; 72(5):389-400. PubMed ID: 28168954
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.